Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Pharmacotherapy|December 1, 2010
Alternative therapies for Clostridium difficile infectionsCharles Venuto, Mary Butler, Elizabeth Dodds Ashley, et al.
Clinical Parkinsonism & Related Disorders|January 23, 2026
Explore thyself: is it time for metacognition screening in clinical trials?Andrew McGarry, Scott Y H Kim, Peggy Auinger, et al.
JAMA Neurology|March 3, 2015
Novel methods and technologies for 21st-century clinical trials: a reviewE Ray Dorsey, Charles Venuto, Vinayak Venkataraman, et al.
Anesthesiology|February 28, 2015
Pharmacokinetics of ε-Aminocaproic Acid in Neonates Undergoing Cardiac Surgery with Cardiopulmonary BypassMichael P Eaton, George M Alfieris, Dawn M Sweeney, et al.
Digital Biomarkers|February 28, 2022
A Smartphone Application as an Exploratory Endpoint in a Phase 3 Parkinson's Disease Clinical Trial: A Pilot StudyAlex Page, Norman Yung, Peggy Auinger, et al.
Pharmacogenetics and Genomics|February 22, 2014
Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202Daniel H Johnson, Charles Venuto, Marylyn D Ritchie, et al.
Pharmacogenetics and Genomics|July 7, 2015
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202Valentine Wanga, Charles Venuto, Gene D Morse, et al.
The Journal of Pediatrics|February 14, 2013
Oral ketamine for children with chronic pain: a pilot phase 1 studyAmy-Lee Bredlau, Michael P McDermott, Heather R Adams, et al.
Pharmacogenetics and Genomics|January 19, 2017
Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202Anurag Verma, Yuki Bradford, Shefali S Verma, et al.
Annals of Clinical and Translational Neurology|June 8, 2017
A novel design of a Phase III trial of isradipine in early Parkinson disease (STEADY-PD III)Kevin M Biglan, David Oakes, Anthony E Lang, et al.
Pageof 2